Alignment Healthcare delivered strong Q4 2025 growth with revenue increasing 44.4% year-over-year to 1012804000 and health plan membership rising 25.0%. The company reported a net loss of 11006000 but generated adjusted EBITDA of 11414000 and achieved an 87.7% medical benefits ratio.

Alignment Healthcare delivered an exceptional third quarter, exceeding its own guidance for membership, revenue, adjusted gross profit, and adjusted EBITDA. The company reported significant year-over-year revenue growth of 43.5% and achieved positive net income, reinforcing the strength and scalability of its care model.

Alignment Healthcare delivered a robust second quarter in 2025, with total revenue reaching $1.015 billion, a 49% increase year-over-year, and health plan membership growing by 27.8% to 223,700. The company surpassed its Q2 guidance for membership, revenue, adjusted gross profit, and adjusted EBITDA, demonstrating strong financial performance and operational efficiency.

Alignment Healthcare delivered strong first quarter 2025 financial results, exceeding the high end of expectations for membership, revenue, adjusted gross profit, and adjusted EBITDA. Total revenue grew 47.5% year over year to $926.9 million, driven by a 31.7% increase in Medicare Advantage membership. The company reported positive adjusted EBITDA and raised the midpoint of its full-year 2025 guidance ranges for key financial and operational metrics, supported by strong clinical performance and enrollment growth.

Alignment Healthcare, Inc. announced strong fourth quarter and full-year 2024 results, with health plan membership significantly increasing by 58.6% year-over-year to 189,100. The company achieved its first full year of positive adjusted EBITDA as a public company, driven by operating leverage and strong medical benefits ratio performance. Total revenue for Q4 2024 was $701.2 million, a 50.7% increase year-over-year.

Alignment Healthcare reported excellent third-quarter results, highlighting their success in delivering high-quality care while effectively managing costs within the Medicare Advantage program. The company's focus on the Triple Aim has driven positive outcomes in stars, growth, and profitability.

Alignment Healthcare reported strong health plan membership growth and margin results for the second quarter of 2024. The company is at an inflection point on both growth and profitability and is positioning itself for another robust year in 2025.

Alignment Healthcare reported strong first quarter results, driven by their Medicare Advantage platform and effective cost management. The company met or exceeded expectations across membership, revenue, adjusted gross profit, and adjusted EBITDA, setting a solid foundation for achieving their full-year outlook.

Alignment Healthcare reported their Q4 and full year results, highlighting their confidence in the Medicare Advantage market and investments made to strengthen medical cost control and member experience.

Alignment Healthcare reported its Q3 2023 financial results, demonstrating strong performance and exceeding expectations across all key financial metrics. The company's success is attributed to its focus on service, quality, and advocacy in Medicare Advantage.

Alignment Healthcare reported its Q2 2023 financial results, surpassing guidance in membership, revenue, adjusted gross profit, and adjusted EBITDA, demonstrating the company's commitment to prioritizing its members and advancing its mission of transforming healthcare.

Alignment Healthcare reported strong first-quarter results, exceeding guidance on membership, revenue, adjusted gross profit, and adjusted EBITDA. The company is focused on clinical excellence and member experience.

Alignment Healthcare reported financial results for the fourth quarter and full year ending Dec. 31, 2022. The company exceeded or met its guidance across all four of its key performance indicators for the eighth consecutive quarter.

Alignment Healthcare reported a solid performance in Q3 2022, driven by strategic investments in people and technology, with their proprietary data platform AVA® playing a key role.

Alignment Healthcare reported strong second-quarter results, exceeding guidance on membership, revenue, adjusted gross profit, and adjusted EBITDA. The company's medical benefits ratio was the lowest since the IPO.

Alignment Healthcare reported a strong first quarter, beating guidance on membership, revenue, adjusted gross profit, and adjusted EBITDA. The company continues to focus on delivering proactive care to seniors and scaling effectively in existing and new markets.

Alignment Healthcare reported strong fourth-quarter results, driven by their clinical model and proprietary AVA® platform. The company is focused on investing in new markets and scaling their differentiated model in 2022.

Alignment Healthcare reported strong financial results for the third quarter ended September 30, 2021, driven by a focus on continuous improvement and leveraging their AVA technology platform.

Alignment Healthcare reported strong second-quarter results, exceeding expectations in membership, revenue, adjusted gross profit, and adjusted EBITDA, leading to an increased full-year outlook for 2021. The company made progress on its growth strategy by entering new states, expanding to contiguous markets, and developing new customer-focused plans, positioning it well for 2022.

Alignment Healthcare reported a 19% increase in total revenue year over year, reaching $267.1 million. Health plan membership grew by 32% to approximately 83,100. The company's adjusted gross profit was $22.6 million, while adjusted EBITDA was $(14.0) million.